Study to Tackle Leading Cause of Death in COVID-19 Patients Lenzilumab, a monoclonal antibody that neutralizes granulocyte macrophage colony stimulating factor (GM-CSF) GM-CSF is up-regulated in COVID-19 ...
|
|
Study to Tackle Leading Cause of Death in COVID-19 Patients Lenzilumab, a monoclonal antibody that neutralizes granulocyte macrophage colony stimulating factor (GM-CSF) GM-CSF is up-regulated in COVID-19 ...
Bookmarks